Franćoise Lejeune

A Comparative In Vitro and In Vivo Pharmacological Characterization of the Novel Dopamine D3Receptor Antagonists (+)-S 14297, Nafadotride, GR 103,691 and U 99194

Valérie Audinot, Adrian Newman‐Tancredi, Alain P. Gobert et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 128 citations

S33084, a Novel, Potent, Selective, and Competitive Antagonist at Dopamine D3-Receptors: I. Receptorial, Electrophysiological and Neurochemical Profile Compared with GR218,231 and L741,626

Mark J. Millan, Alain P. Gobert, Adrian Newman‐Tancredi et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 125 citations · Full text

S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models

Anne Dekeyne, Clotilde Mannoury la Cour, Alain P. Gobert et al. · Psychopharmacology · 2008 · 124 citations

Psychiatry, Functional Selectivity, Medicine +12

S 18126 ({2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl}), a Potent, Selective and Competitive Antagonist at Dopamine D4 Receptors: An In Vitro and In Vivo Comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2,3b]pyridine) and Raclopride

Mark J. Millan, Adrian Newman‐Tancredi, Mauricette Brocco et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 73 citations

Activation of dopamine D3 autoreceptors inhibits firing of ventral tegmental dopaminergic neurones in vivo

Franćoise Lejeune, Mark J. Millan · European Journal of Pharmacology · 1995 · 66 citations

Neurobiological Mechanism, Neuroanatomy, Dopamine D3 Autoreceptors +11